Valuation: Numinus Wellness Inc.

Capitalization 19.82M 14.4M 12.39M 11.33M 10.81M 1.38B 20.14M 136M 52.6M 656M 54.04M 52.88M 2.28B P/E ratio 2023
-1.72x
P/E ratio 2024 -0.48x
Enterprise value 19.89M 14.45M 12.44M 11.37M 10.85M 1.39B 20.22M 136M 52.79M 658M 54.24M 53.08M 2.29B EV / Sales 2023
2.21x
EV / Sales 2024 2.48x
Free-Float
98.26%
Yield 2023 *
-
Yield 2024 -
3 years 0.02
Extreme 0.025
0.28
5 years 0.02
Extreme 0.025
1.18
10 years 0.02
Extreme 0.025
2.45
Manager TitleAgeSince
Chief Executive Officer - 2025-01-22
Director of Finance/CFO - 2025-02-17
Chief Tech/Sci/R&D Officer - 2022-06-09
Director TitleAgeSince
Chairman - 1962-06-25
Director/Board Member - 2020-05-14
Director/Board Member 69 2019-01-27
Change 5d. change 1-year change 3-years change Capi.($)
-.--%-.--% - - 12.85M
-1.01%-2.82%-18.17%-19.32% 41.67B
-3.73%-6.04%+28.41%+22.76% 32.6B
-2.55%+2.71%+268.39%+468.32% 30.97B
-0.91%-5.37%+18.41%-11.55% 28.23B
-3.23%-4.84%+27.50%+22.65% 26.41B
-2.03%+0.77% - - 14.94B
+6.21%-2.39%+176.35%+4,385.95% 14.13B
-1.92%-1.95%+121.19%+106.25% 12.27B
-0.20%-0.10%+5.63%-1.89% 12.12B
Average -0.94%-1.83%+78.46%+621.65% 23.7B
Weighted average by Cap. -1.51%-2.18%+69.42%+393.03%

Financials

2023 2024
Net sales 23.18M 16.84M 14.49M 13.25M 12.64M 1.62B 23.56M 159M 61.53M 767M 63.21M 61.86M 2.67B 4.17M 3.03M 2.61M 2.38M 2.27M 291M 4.24M 28.59M 11.06M 138M 11.37M 11.12M 481M
Net income -30.26M -21.99M -18.92M -17.3M -16.5M -2.11B -30.76M -208M -80.31M -1B -82.51M -80.74M -3.49B -19.64M -14.27M -12.28M -11.23M -10.71M -1.37B -19.97M -135M -52.14M -650M -53.57M -52.42M -2.26B
Net Debt -1.38M -1M -863K -789K -753K -96.22M -1.4M -9.47M -3.66M -45.68M -3.76M -3.68M -159M 74.32K 54K 46.47K 42.49K 40.54K 5.18M 75.54K 510K 197K 2.46M 203K 198K 8.57M
Logo Numinus Wellness Inc.
Numinus Wellness Inc. is a mental healthcare company. It focuses on advancing traditional and behavioral health treatments, including safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training develops tailored education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. It is the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Employees
-

Quarterly revenue - Rate of surprise